Prof. Dr. Rafet Eren is a hematologist specializing in lymphoma, acute and chronic leukaemias, multiple myeloma, myeloproliferative diseases, immune thrombocytopenia, anaemia, thalassaemia, and haemophilia. He graduated from Istanbul Faculty of Medicine in 2007
Papers Presented at International Scientific Meetings
- How Does 2016 WHO Criteria for Polycythemia Vera Contribute to Our Daily Practice? A Single-Center Study from Turkey – 25th Congress of EHA (2020)
- Beta Thalassemia minor: patients are not tired but depressed and anxious – 24th Congress of EHA (2019)
- Evaluation of neutrophil-lymphocyte ratio in patients with mycosis fungoides – 21st Congress of EHA (2016)
- Effect of vitamin D deficiency and replacement on endothelial functions in familial Mediterranean fever – EULAR 2014
Polypharmacy in Hematology Practice: A Single Center Experience – EHA Hemasphere (2023)
Book Chapters
Transfusion Reactions – Current Diagnosis and Treatment in Holistic Medicine, Family Medicine, Internal Branches, Hematology, Chapter 25, pp. 1285–1286
Kikuchi-Fujimoto's Disease – Current Approaches in Hematology (2019)
Staging and Prognosis in Chronic Lymphocytic Leukemia – 2019 Update in Chronic Lymphocytic Leukemia (2019)and completed his Internal Medicine specialty training at Marmara University Faculty of Medicine in 2012. In 2018, he became a Hematology subspecialist at Istanbul Training and Research Hospital, and in 2019 was awarded the title of Associate Professor in the field of Hematology. He subsequently worked as a faculty member at Başakşehir Çam and Sakura City Hospital, Bozyaka Training and Research Hospital, and Istinye University (Istinye University Bahçeşehir and Liv Hospital Vadistanbul), and currently practices at Biruni University Faculty of Medicine Hospital. He has around 50 publications in national and international refereed journals and is a member of the Turkish Hematology Association, the Hematology Specialty Society, the Turkish Internal Medicine Specialty Society, and the European Society of Hematology.
Education
-
Associate Professor (Hematology Clinic)
Prof. Dr. Cemil Taşçıoğlu Training and Research Hospital
2019
-
Ph.D. (Hematology Clinic)
Istanbul Training and Research Hospital
2018
-
Master's Degree (Department of Internal Medicine)
Marmara University Faculty of Medicine
2012
-
Undergraduate Education
Istanbul University Istanbul Faculty of Medicine
2007
Academic & Administrative Roles
-
Associate Professor, M.D.
Biruni University Faculty of Medicine Hospital
2023–Present
-
Associate Professor, M.D.
Istinye University Faculty of Medicine, Department of Internal Medicine, Liv Vadistanbul Hospital
2021–2023
-
Associate Professor, M.D.
Bozyaka Training and Research Hospital, Hematology Clinic
2020–2021
-
Associate Professor, M.D.
Istanbul Başakşehir Çam and Sakura City Hospital, Hematology Clinic
2020
-
Associate Professor, M.D.
Prof. Dr. Cemil Taşçıoğlu Training and Research Hospital, Hematology Clinic
2019–2020
-
Specialist, M.D.
Prof. Dr. Cemil Taşçıoğlu Training and Research Hospital, Hematology Clinic
2018–2019
-
Subspecialty Resident, M.D.
Istanbul Training and Research Hospital, Hematology Clinic
2015–2018
-
Specialist, M.D.
Mardin Derik State Hospital
2013–2015
-
Resident Physician
Marmara University Faculty of Medicine, Department of Internal Medicine
2008–2012
-
General Practitioner
Mardin Derik Boyaklı Health Center
2008
-
Resident Physician
Istanbul University Cerrahpaşa Faculty of Medicine, Department of General Surgery
2007–2008
- Turkish Hematology Association
- Hematology Specialty Society
- Turkish Internal Medicine Specialty Society
- European Society of Hematology
-
Rethinking the usefulness of bone marrow biopsy on treatment decision in CLL patients at diagnosis
Ann Hematol · 2017 -
Comparison of clinical features and survival between young and old chronic lymphocytic leukemia patients: a single center study from Turkey
Leuk Lymphoma · 2019 -
The impact of bulky mass on treatment response and overall survival in patients with diffuse large b-cell lymphoma in rituximab era
UHOD · 2018 -
Evaluation of neutrophil-lymphocyte ratio in patients with early-stage mycosis fungoides
Ann Hematol · 2016 -
Beta Thalassemia Minor: Patients are not Tired but Depressed and Anxious
Med Princ Pract · 2020 -
Evaluation of the Reliability of Interim PET/CT in the Hodgkin Lymphoma
Curr Med Imaging Rev · 2020 -
Autologous stem cell transplantation and stem cell mobilization kinetics in elderly patients with B cell non-Hodgkin lymphoma
Transfus Apher Sci · 2017 -
Stem cell mobilization kinetics in elderly patients with multiple myeloma
Transfus Apher Sci · 2018 -
How Does 2016 WHO Criteria for Polycythemia Vera Contribute to Our Daily Practice? A Single-Center Study from Turkey
International Journal of Hematology-Oncology and Stem Cell Research · 2020 -
Prevalence of inflammatory back pain and radiologic sacroiliitis is increased in patients with primary Sjögren's syndrome
Pan Afr Med J · 2018 -
The association of mean platelet volume and platecrit and bone marrow fibrosis in patients with essential thrombocythemia: A cohort study
J Surg Med · 2019 -
The Association of Globulin Level with Treatment Response and Overall Survival in Patients with Multiple Myeloma
EJMO · 2018 -
Are We Aware of Anxiety and Depression in Patients with Newly Diagnosed Acute Leukemia?
J Gen Pract · 2017 -
Vitamin D Deficiency and its Effects on Patients with Multiple Myeloma
Hematol Transfus Int J · 2017 -
Eltrombopag in the Treatment of Immune Thrombocytopenia: Two-Center Experience from Istanbul
Indian J Hematol Blood Transfus · 2022 -
Comparison of Splenectomy and Eltrombopag Treatment in the Second-Line Treatment of Immune Thrombocytopenic Purpura
Turk J Haematol · 2021 -
A Real-life Turkish Experience of Venetoclax Treatment in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia
Clin Lymphoma Myeloma Leuk · 2021 -
The Effect of Serum Lactate Dehydrogenase (LDH) Level on the Response to Erythropoiesis Stimulating Agents in Patients with Low and Intermediate Risk Myelodysplastic Syndrome
J Haematol Stem Cell Res · 2021 -
Quality of life assessment with EORTC QLQ in patients with hodgkin lymphoma: Multicenter study
Acta Oncologica Turcica · 2022 -
Survival in patients with multiple myeloma: evaluation of possible associations with bone marrow fibrosis and investigation of factors independently associated with survival
Bull Natl Res Cent · 2022 -
Charlson Comorbidity Index (CCI) in Diffuse Large B-cell Lymphoma: A New Approach in a Multicenter Study
Indian J Hematol Blood Transfus · 2023 -
The Obesity Controversy: Does It Impact Treatment Response in Diffuse Large B-Cell Lymphoma?
Int J Hematol Oncol Stem Cell Res · 2023
-
Young Researcher Award
42nd National Hematology Congress
2016
-
Special Jury Paper Award
3rd Hematologic Oncology Congress
2015
-
Paper 3rd Prize
2nd Hematologic Oncology and Bone Marrow Transplantation Symposium
2016